| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CMO | Chief Medical Officer
2 companies
Donovan Joanne M. is a CMO at Edgewise Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $155K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | EWTX Edgewise Therapeutics, Inc. | CMO | Sale+OE | 55,230 | $37.88 | $2,092,062.91 | -86.3% | - | - | |
| Mar 31, 2026 | EWTX Edgewise Therapeutics, Inc. | CMO | Sale+OE | 21,338 | $32.12 | $685,308.28 | -69.0% | - | - | |
| Mar 27, 2026 | EWTX Edgewise Therapeutics, Inc. | CMO | Sell | 16,358 | $30.98 | $506,734.85 | -38.7% | - | - | |
| Aug 12, 2025 | EWTX Edgewise Therapeutics, Inc. | CMO | Sale+OE | 2,862 | $13.39 | $38,329.05 | -10.1% | +36.5% | - | |
| May 2, 2025 | EWTX Edgewise Therapeutics, Inc. | CMO | Sale+OE | 5,187 | $16.45 | $85,347.94 | -19.4% | -15.7% | +81.0% | |
| Jan 28, 2025 | EWTX Edgewise Therapeutics, Inc. | CMO | Sale+OE | 25,000 | $27.63 | $690,657.50 | -60.4% | -43.6% | +3.2% | |
| Sep 20, 2024 | EWTX Edgewise Therapeutics, Inc. | CMO | Sell | 7,162 | $28.29 | $202,602.95 | -33.0% | +8.9% | -49.6% | |
| May 2, 2024 | EWTX Edgewise Therapeutics, Inc. | CMO | Sale+OE | 3,682 | $18.91 | $69,626.62 | -15.6% | -11.7% | -12.3% | |
| May 2, 2023 | EWTX Edgewise Therapeutics, Inc. | CMO | Sale+OE | 3,254 | $8.90 | $28,976.54 | -24.6% | -16.7% | +117.3% |